Brief Information of the Cell Line and Protein
Cell Line ID: CL000020 , Neuro-2a
Synonyms
NEURO-2A
Neuro 2a
Neuro2a
Neuro2A
N-2a
N2a
N2A
Nb2a
NB2a
Category Cancer cell line
Organism
Mus musculus (Mouse)
Cellosaurus ID
CVCL_0470
Protein ID: PT06166 , Nociceptin receptor
Gene Name OPRL1
Organism Mus musculus, Mouse
Protein Classification Membrane receptor
Uniprot ID P35377
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000020  Protein ID: PT06166
 
Compound ID Compound Name Compound Formula
CP0381385
(2S,5S,8S,11S,19S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S,5S,8S,11S,19S)-2-(4-aminobutyl)-5-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-11-carbamoyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicos-19-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-5-(4-aminobutyl)-19-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetyl]amino]acetyl]amino]-3-(4-fluorophenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-2-[3-(diaminomethylideneamino)propyl]-8-(hydroxymethyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C90H145FN32O24
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0377738
(2S,5S,8S,11S,19S)-19-[[(2S,5S,8S,11S,19S)-19-[[(2S,3R)-2-acetamido-3-hydroxybutanoyl]amino]-8-(4-aminobutyl)-5-[3-(diaminomethylideneamino)propyl]-2-methyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carbonyl]amino]-5-(4-aminobutyl)-2-[3-(diaminomethylideneamino)propyl]-8-(2-methylpropyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C59H106N22O15
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0413205
(2S,5S,8S,11S,19S)-19-acetamido-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S,5S,8S,11S,19S)-2-(4-aminobutyl)-5-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-11-carbamoyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicos-19-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-5-(4-aminobutyl)-2-[3-(diaminomethylideneamino)propyl]-8-(hydroxymethyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C64H114N26O18
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0501673
(2S,5S,8S,11S,19S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S,5S,8S,11S,19S)-2-(4-aminobutyl)-5-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-11-carbamoyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicos-19-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-5-(4-aminobutyl)-19-[[2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]acetyl]amino]-2-[3-(diaminomethylideneamino)propyl]-8-(hydroxymethyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C68H122N28O20
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0511674
(2S,5S,8S,11S,19S)-5-(4-aminobutyl)-19-[[(2S,5S,8S,11S,19S)-8-(4-aminobutyl)-19-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[(2-benzamidoacetyl)amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-5-[3-(diaminomethylideneamino)propyl]-2-methyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carbonyl]amino]-2-[3-(diaminomethylideneamino)propyl]-8-(2-methylpropyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C79H126N26O19
 1
1
IC50 > 100 nM
   TI
   LI
   LO
   TS
CP0394887
(2S,5S,8S,11S,19S)-N-[(2S)-1-[[(2S)-6-amino-1-[[(2S,5S,8S,11S,19S)-2-(4-aminobutyl)-5-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-11-carbamoyl-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicos-19-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-5-(4-aminobutyl)-19-[[2-[[(2S,3R)-2-[[(2S)-2-[[2-[[2-[(2-benzamidoacetyl)amino]acetyl]amino]acetyl]amino]-3-(4-fluorophenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-2-[3-(diaminomethylideneamino)propyl]-8-(hydroxymethyl)-3,6,9,13,20-pentaoxo-1,4,7,10,14-pentazacycloicosane-11-carboxamide
   Show/Hide
C90H143FN32O25
 1
1
Kd = 1.95 nM
   TI
   LI
   LO
   TS